US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

TRAWS PHARMA

1.41

-0.0800-5.37%

Post-market: 1.410.00000.00%18:09 EDT

Volume:30.62K

Turnover:44.09K

Market Cap:7.21M

PE:-0.04

High:1.48

Open:1.46

Low:1.41

Close:1.49

Loading ...

Overview Company News Filings

Risk Aversion Grips Wall Street in Penultimate Session of 2024, Fueling Premarket Losses for US Equity Futures

MT Newswires Live

Traws Pharma announces $72.6M financing

Traws Pharma, Inc. Announces Financing up to $72.6 Million From Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5n1 Bird Flu to Approval

THOMSON REUTERS

Press Release: Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval

Traws Pharma Inc trading halted, volatility trading pause

Traws Pharma Inc trading halted, volatility trading pause

Traws Pharma Shares More Than Double After Its Experimental Bird Flu Drug Is Safe and Tolerable in Early Stage Study

THOMSON REUTERS

Traws Pharma Shares Surge 83% on Development of Bird Flu Treatment

Investors Look to Reverse Last Week's Slide as US Futures Mixed Monday Pre-Bell

MT Newswires Live

BUZZ-Traws Pharma more than doubles on early-stage success of bird flu drug

Traws Pharma Shares More Than Double Premarket After Its Experimental Bird Flu Drug Is Safe and Tolerable in Early Stage Study

THOMSON REUTERS

Traws Pharma announces progress in the development of tivoxavir marboxil

Traws Pharma-in Vivo Study in Mice,With H5n1 Isolated From Infected Dairy Worker, Showed Potent Protection & Suppression of Virus Replication in Lungs

THOMSON REUTERS

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5n1 Bird Flu

THOMSON REUTERS

Traws Pharma Inc - Phase 2 Study Expected to Begin in H1 2025

THOMSON REUTERS

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu

Noble Financial Sticks to Their Buy Rating for Traws Pharma (TRAW)

BRIEF-Traws Pharma - On Nov 20, Receives Nasdaq Non-Compliance Notice As Co Fails To Meet Nasdaq Listing Rule

Traws Pharma Faces Uncertain Future Amid Complex Onconova Merger

Traws Pharma Inc reports results for the quarter ended September 30 - Earnings Summary

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TRAW/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRAW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAW\",,,,,undefined,":{"symbol":"TRAW","market":"US","secType":"STK","nameCN":"TRAWS PHARMA","latestPrice":1.41,"timestamp":1746648000000,"preClose":1.49,"halted":0,"volume":30619,"hourTrading":{"tag":"盘后","latestPrice":1.41,"preClose":1.41,"latestTime":"18:09 EDT","volume":52,"amount":76.96,"timestamp":1746655788337},"delay":0,"floatShares":4159569,"shares":5115900,"eps":-35.21255,"marketStatus":"Not Yet Opened","change":-0.08,"latestTime":"05-07 16:00:00 EDT","open":1.46,"high":1.48,"low":1.41,"amount":44089.492241,"amplitude":0.04698,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-35.21255,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746691200000},"marketStatusCode":0,"adr":0,"listingDate":1374724800000,"exchange":"NASDAQ","adjPreClose":1.49,"preHourTrading":{"tag":"盘前","latestPrice":1.57,"preClose":1.49,"latestTime":"08:00 EDT","volume":10,"amount":15.700000000000001,"timestamp":1746619200744},"postHourTrading":{"tag":"盘后","latestPrice":1.41,"preClose":1.41,"latestTime":"18:09 EDT","volume":52,"amount":76.96,"timestamp":1746655788337},"volumeRatio":0.80506,"impliedVol":1.7917,"impliedVolPercentile":0.7789},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAW\",,,,,undefined,":{"symbol":"TRAW","floatShares":4159569,"roa":"-65.35%","roe":"-2255.45%","lyrEps":-35.212551,"volumeRatio":0.80506,"shares":5115900,"dividePrice":0,"high":1.48,"amplitude":0.04698,"preClose":1.49,"low":1.41,"week52Low":1.36,"pbRate":"-0.23","psRate":"31.92","week52High":19.44,"institutionHeld":0,"latestPrice":1.41,"eps":-35.21255,"divideRate":0,"volume":30619,"delay":0,"ttmEps":-35.21255,"open":1.46,"prevYearClose":8.88,"prevWeekClose":1.42,"prevMonthClose":1.45,"prevQuarterClose":2.3,"fiveDayClose":1.45,"twentyDayClose":1.74,"sixtyDayClose":7.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRAW\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2495470035","title":"Risk Aversion Grips Wall Street in Penultimate Session of 2024, Fueling Premarket Losses for US Equity Futures","url":"https://stock-news.laohu8.com/highlight/detail?id=2495470035","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495470035?lang=en_us&edition=fundamental","pubTime":"2024-12-30 22:00","pubTimestamp":1735567203,"startTime":"0","endTime":"0","summary":"US equity futures dropped ahead of Monday's opening bell as traders turned risk-averse in the penultimate trading session of 2024.The Dow Jones Industrial Average futures slipped 1%, S&P 500 futures d","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TSYW.SI","SDOW","USAW.SI","USJW.SI","NQmain","DOG",".IXIC","TQQQ","TRAW",".DJI","QLD","DXD","NVIW.SI","BK4585","BK4215","DJX","SQQQ","DDM",".SPX","QID","UDOW","MNQmain","BK4007","BK4588","PSQ","EQR","PLRZ"],"gpt_icon":1},{"id":"2495542415","title":"Traws Pharma announces $72.6M financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2495542415","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495542415?lang=en_us&edition=fundamental","pubTime":"2024-12-30 21:30","pubTimestamp":1735565429,"startTime":"0","endTime":"0","summary":"Traws Pharma (TRAW) “announced that it has entered into definitive agreements to raise up to $72.6 million before deduction of placement agent’s fe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/traws-pharma-announces-72-6m-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/traws-pharma-announces-72-6m-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2495541162","title":"Traws Pharma, Inc. Announces Financing up to $72.6 Million From Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5n1 Bird Flu to Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2495541162","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495541162?lang=en_us&edition=fundamental","pubTime":"2024-12-30 21:00","pubTimestamp":1735563623,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nTUA1MTS7S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2495854117","title":"Press Release: Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2495854117","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495854117?lang=en_us&edition=fundamental","pubTime":"2024-12-30 21:00","pubTimestamp":1735563600,"startTime":"0","endTime":"0","summary":"Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval. Initial tranche of $20 Million extends cash runway into 1H26, subsequent tranche of up to $52.6 Million will provide for runway 3+ years enabling the company to reach both near-term and long-term value inflecting readouts. \"We are appreciative of the support from new and existing institutional investors including Perceptive Advisors, OrbiMed, Alyeska, Torrey Pines and Ikarian Capital. This financing by high quality investors is transformative for Traws and highlights the meaningful potential for Tivoxavir Marboxil,\" said Iain D. Dukes, MA, DPhil, Executive Chairman of Traws Pharma and Venture Partner of OrbiMed.Traws Pharma will host an update call on Tivoxavir Marboxil during the first quarter of 2025 with additional details forthcoming.This announcement is neither an offer to sell, nor a solicitation of an ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CEN","BK4007","BK4181","BK4211","ISBC","CDC","HCSG","TRAW","BK4137","PK","BK4218"],"gpt_icon":1},{"id":"2494381337","title":"Traws Pharma Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2494381337","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494381337?lang=en_us&edition=fundamental","pubTime":"2024-12-27 23:05","pubTimestamp":1735311914,"startTime":"0","endTime":"0","summary":"10:03 EST Traws Pharma (TRAW) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-mo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/traws-pharma-inc-trading-halted-volatility-trading-pause-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/traws-pharma-inc-trading-halted-volatility-trading-pause-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2493073765","title":"Traws Pharma Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2493073765","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493073765?lang=en_us&edition=fundamental","pubTime":"2024-12-23 22:40","pubTimestamp":1734964819,"startTime":"0","endTime":"0","summary":"09:39 EST Traws Pharma (TRAW) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-mo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/traws-pharma-inc-trading-halted-volatility-trading-pause-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/traws-pharma-inc-trading-halted-volatility-trading-pause-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2493656387","title":"Traws Pharma Shares More Than Double After Its Experimental Bird Flu Drug Is Safe and Tolerable in Early Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2493656387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493656387?lang=en_us&edition=fundamental","pubTime":"2024-12-23 22:33","pubTimestamp":1734964416,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nFWN3NO0HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2493757059","title":"Traws Pharma Shares Surge 83% on Development of Bird Flu Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2493757059","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493757059?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:28","pubTimestamp":1734960480,"startTime":"0","endTime":"0","summary":"Traws Pharma shares surged 83% after the company disclosed progress in the development of tivoxavir marboxil as a treatment for HSN1 bird flu.Shares jumped to $9.16. The stock is down 73% on the year.The clinical-stage biopharmaceutical company said current topline data from a Phase 1 trial showed that a single dose of the treatment maintained plasma drug levels consistently above EC for more than 23 days with higher dose dating coming.\"This result is highly encouraging for future clinical development of tivoxavir marboxil for treating human H5N1 influenza,\" said Chief Science Officer C. David Pauza.Bird flu is once again an issue to watch. California last week declared a state of emergency due to an increased number of H5N1 bird flu cases that have been detected in the state's dairy cows.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Traws Pharma Shares Surge 83% on Development of Bird Flu Treatment","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"gpt_icon":1},{"id":"2493875240","title":"Investors Look to Reverse Last Week's Slide as US Futures Mixed Monday Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2493875240","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493875240?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:08","pubTimestamp":1734959307,"startTime":"0","endTime":"0","summary":"US stock futures are mixed in Monday's premarket session as investors hope to reverse last week losses during the holiday-shortened week.The Dow Jones Industrial Average futures were down 0.2%, S&P 50","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4211","ISBC","IE00B19Z4B17.USD","RUM","BK4077","BK4139","MG","BK4539","IE00B66KJ199.SGD","BK4516","PHIO","TRAW","IE00B7SZL793.SGD","BK4007","DSGN","IE0031619046.USD","BK4123","PBM","BK4505"],"gpt_icon":1},{"id":"2493461752","title":"BUZZ-Traws Pharma more than doubles on early-stage success of bird flu drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2493461752","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493461752?lang=en_us&edition=fundamental","pubTime":"2024-12-23 21:04","pubTimestamp":1734959090,"startTime":"0","endTime":"0","summary":"BUZZ-Traws Pharma more than doubles on early-stage success of bird flu drug ** Traws Pharma's TRAW.O shares soar 129% to $11.30 premarket** TRAW says its experimental bird flu drug, tivoxavir marboxil, was safe and well-tolerated in early-stage trial** A single dose maintained levels of the drug in the blood for over 23 days in the trial, co says** Mid-stage trial is expected to begin in H1 2025, co says** Bird flu has infected more than 860 dairy herds in 16 U.S. states since March and killed 123 million poultry since the outbreak began in 2022** As of last close, stock has fallen 73.2% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nL4N3NO0P4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2493023759","title":"Traws Pharma Shares More Than Double Premarket After Its Experimental Bird Flu Drug Is Safe and Tolerable in Early Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2493023759","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493023759?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:22","pubTimestamp":1734956523,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nFWN3NO09O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2493475906","title":"Traws Pharma announces progress in the development of tivoxavir marboxil","url":"https://stock-news.laohu8.com/highlight/detail?id=2493475906","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493475906?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:16","pubTimestamp":1734956176,"startTime":"0","endTime":"0","summary":"Traws Pharma (TRAW) announced progress in the development of its investigational one-dose influenza investigational therapy, tivoxavir marboxil for...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/traws-pharma-announces-progress-in-the-development-of-tivoxavir-marboxil?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/traws-pharma-announces-progress-in-the-development-of-tivoxavir-marboxil?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2493756768","title":"Traws Pharma-in Vivo Study in Mice,With H5n1 Isolated From Infected Dairy Worker, Showed Potent Protection & Suppression of Virus Replication in Lungs","url":"https://stock-news.laohu8.com/highlight/detail?id=2493756768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493756768?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:00","pubTimestamp":1734955205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nTUA3HLVQN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"2493756401","title":"Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5n1 Bird Flu","url":"https://stock-news.laohu8.com/highlight/detail?id=2493756401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493756401?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:00","pubTimestamp":1734955205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nTUA3HLVQN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2493756258","title":"Traws Pharma Inc - Phase 2 Study Expected to Begin in H1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2493756258","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493756258?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:00","pubTimestamp":1734955205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nTUA3HLVQN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2493751469","title":"Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu","url":"https://stock-news.laohu8.com/highlight/detail?id=2493751469","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493751469?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:00","pubTimestamp":1734955200,"startTime":"0","endTime":"0","summary":"Investigational agent in development for treatment or prevention of H5N1 Bird Flu. Potent inhibition of drug-resistant and bird flu viruses in vitro. In vivo study in mice, with H5N1 isolated from an infected dairy worker, showed potent protection and suppression of virus replication in lungs. Traws Pharma is expanding its influenza program to address the potential threat of bird flu. \"In laboratory testing, tivoxavir marboxil inhibited multiple isolates of highly pathogenic avian influenza H5N1. We evaluated the effects of drug treatment in mice exposed to human H5N1, where the virus was isolated from a dairy worker exposed to infected cattle,\" said C. David Pauza, PhD, Chief Science Officer for Traws Pharma. \"Oral treatment with tivoxavir marboxil after the virus infection resulted in complete survival and lung virus levels below the limit of quantitation1. This result is highly encouraging for future clinical development of tivoxavir marboxil for treating human H5N1 influenza.\". No ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/YVNx2oT9dYISFKmaBZL4mA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/fa5b4fbc1407c77b5c22d9507acdc357","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/YVNx2oT9dYISFKmaBZL4mA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/fa5b4fbc1407c77b5c22d9507acdc357"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/traws-pharma-announces-progress-developing-120000871.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/traws-pharma-announces-progress-developing-120000871.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4097","CDC","BK4007","CEN","LU2065732104.USD","PK","BK4181","BK4218","PRGS","TRAW"],"gpt_icon":0},{"id":"2486417821","title":"Noble Financial Sticks to Their Buy Rating for Traws Pharma (TRAW)","url":"https://stock-news.laohu8.com/highlight/detail?id=2486417821","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486417821?lang=en_us&edition=fundamental","pubTime":"2024-11-27 21:25","pubTimestamp":1732713931,"startTime":"0","endTime":"0","summary":"In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on Traws Pharma (TRAW – Research Report), with a price targ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/noble-financial-sticks-to-their-buy-rating-for-traws-pharma-traw?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/noble-financial-sticks-to-their-buy-rating-for-traws-pharma-traw?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAW","NBL"],"gpt_icon":0},{"id":"2485217090","title":"BRIEF-Traws Pharma - On Nov 20, Receives Nasdaq Non-Compliance Notice As Co Fails To Meet Nasdaq Listing Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2485217090","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485217090?lang=en_us&edition=fundamental","pubTime":"2024-11-23 06:05","pubTimestamp":1732313131,"startTime":"0","endTime":"0","summary":"Nov 22 (Reuters) - Traws Pharma Inc   :   * TRAWS PHARMA - ON NOV 20, RECEIVES NASDAQ NON-COMPLIANCE NOTICE AS CO FAILS TO MEET NASDAQ LISTING RULE 5550(B)(1)Source text: [ Further company coverage:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ199S13.USD","LU2210149790.SGD","LU1720051017.SGD","BK4141","BK4007","LU2357305700.SGD","LU2210150020.SGD","SQQQ","LU2360107325.USD","NDAQ",".IXIC","ON","TQQQ","BK4588","LU1861214812.USD","QID","LU1861220033.SGD","BK4585","LU0348723411.USD","IE00B64PRP62.GBP","BK4161","LU0124384867.USD","LU1861215975.USD","LU1861219969.SGD","MNQmain","QLD","IE00BKPKM429.USD","LU1854104046.USD","B","LU1978683503.SGD","LU2298322129.HKD","IE00BD6J9T35.USD","LU1854103824.USD","BK4512","LU2095319765.USD","PSQ","TRAW","NQmain","LU1548497426.USD","LU1720051108.HKD","BK4112","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU0724618433.USD"],"gpt_icon":0},{"id":"2483561861","title":"Traws Pharma Faces Uncertain Future Amid Complex Onconova Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2483561861","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483561861?lang=en_us&edition=fundamental","pubTime":"2024-11-16 14:01","pubTimestamp":1731736869,"startTime":"0","endTime":"0","summary":"Traws Pharma, Inc. (TRAW) has disclosed a new risk, in the Corporate Activity and Growth category. The integration of Onconova and Trawsfynydd pose...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/traws-pharma-faces-uncertain-future-amid-complex-onconova-merger?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/traws-pharma-faces-uncertain-future-amid-complex-onconova-merger?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2483737111","title":"Traws Pharma Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483737111","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483737111?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:10","pubTimestamp":1731679833,"startTime":"0","endTime":"0","summary":"* Traws Pharma Inc    reported a quarterly adjusted loss of $8.81 per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of $-5.75.  The mea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Traws Pharma Inc reports results for the quarter ended September 30 - Earnings Summary","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":64,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRAW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"TRAW","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":95.66},{"market":"US","date":"2024-11-14","symbol":"TRAW","fiscalQuarterEnding":"2024/09","expectedEps":-6.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-8.81},{"market":"US","date":"2024-09-23","symbol":"TRAW","defaultRemindTime":1727098200000,"type":"split","dateTimestamp":1727064000000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2024-08-15","symbol":"TRAW","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723694400000,"reportTimeType":"pre","actualEps":-4.87},{"market":"US","date":"2024-05-15","symbol":"TRAW","fiscalQuarterEnding":"2024/03","expectedEps":-0.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-0.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRAW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRAW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRAW\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRAW","date":"2025-05-06","current":-0.045704,"percent":0.980237,"low":-0.930105,"twenty":-0.670346,"median":-0.111536,"eighty":-0.066096,"high":-0.042961,"avg":-0.274867,"sd":0.28349,"marketCap":7610685},"quantilePoints":[{"date":"2024-04-05","current":-0.930105,"twenty":-0.930105,"median":-0.930105,"eighty":-0.930105,"marketCap":17623624},{"date":"2024-04-12","current":-0.875242,"twenty":-0.899279,"median":-0.879971,"eighty":-0.87246,"marketCap":16584087},{"date":"2024-04-19","current":-0.774197,"twenty":-0.884701,"median":-0.859217,"eighty":-0.774642,"marketCap":14669484},{"date":"2024-04-26","current":-0.703922,"twenty":-0.875242,"median":-0.784323,"eighty":-0.745597,"marketCap":13337908},{"date":"2024-05-03","current":-0.713993,"twenty":-0.87246,"median":-0.75973,"eighty":-0.713993,"marketCap":13528735},{"date":"2024-05-10","current":-0.722239,"twenty":-0.859217,"median":-0.743093,"eighty":-0.71377,"marketCap":13684982},{"date":"2024-05-17","current":-0.7463,"twenty":-0.799236,"median":-0.738475,"eighty":-0.713993,"marketCap":13549821},{"date":"2024-05-24","current":-0.73457,"twenty":-0.794005,"median":-0.741761,"eighty":-0.718444,"marketCap":13336853},{"date":"2024-05-31","current":-0.675921,"twenty":-0.778515,"median":-0.736522,"eighty":-0.713681,"marketCap":12272014},{"date":"2024-06-07","current":-0.836261,"twenty":-0.794624,"median":-0.73457,"eighty":-0.711322,"marketCap":15183160},{"date":"2024-06-14","current":-0.873049,"twenty":-0.83888,"median":-0.740589,"eighty":-0.71288,"marketCap":15851082},{"date":"2024-06-21","current":-0.649387,"twenty":-0.836845,"median":-0.738475,"eighty":-0.709541,"marketCap":11790270},{"date":"2024-06-28","current":-0.62709,"twenty":-0.83835,"median":-0.738475,"eighty":-0.706993,"marketCap":11385454},{"date":"2024-07-05","current":-0.557395,"twenty":-0.836651,"median":-0.734469,"eighty":-0.698614,"marketCap":10120072},{"date":"2024-07-12","current":-0.483661,"twenty":-0.814046,"median":-0.728873,"eighty":-0.672205,"marketCap":8781358},{"date":"2024-07-15","current":-0.554747,"twenty":-0.806641,"median":-0.726171,"eighty":-0.663181,"marketCap":10071990},{"date":"2024-08-02","current":-0.532446,"twenty":-0.799236,"median":-0.724978,"eighty":-0.649387,"marketCap":9667086},{"date":"2024-08-09","current":-0.491259,"twenty":-0.797102,"median":-0.722239,"eighty":-0.600613,"marketCap":8919304},{"date":"2024-08-16","current":-0.066488,"twenty":-0.794005,"median":-0.718444,"eighty":-0.532446,"marketCap":9112137},{"date":"2024-08-23","current":-0.065565,"twenty":-0.774642,"median":-0.71377,"eighty":-0.508851,"marketCap":8985580},{"date":"2024-08-30","current":-0.06743,"twenty":-0.774197,"median":-0.709986,"eighty":-0.494812,"marketCap":9241226},{"date":"2024-09-06","current":-0.06538,"twenty":-0.762623,"median":-0.702951,"eighty":-0.490604,"marketCap":8960268},{"date":"2024-09-13","current":-0.062794,"twenty":-0.758648,"median":-0.694503,"eighty":-0.071087,"marketCap":8605907},{"date":"2024-09-20","current":-0.057254,"twenty":-0.751084,"median":-0.683063,"eighty":-0.068232,"marketCap":7846562},{"date":"2024-09-27","current":-0.081301,"twenty":-0.74722,"median":-0.649387,"eighty":-0.067774,"marketCap":11142278},{"date":"2024-10-04","current":-0.073971,"twenty":-0.746382,"median":-0.624791,"eighty":-0.068232,"marketCap":10137646},{"date":"2024-10-11","current":-0.065174,"twenty":-0.745738,"median":-0.557395,"eighty":-0.067596,"marketCap":8932088},{"date":"2024-10-18","current":-0.062642,"twenty":-0.744673,"median":-0.543597,"eighty":-0.067316,"marketCap":8585034},{"date":"2024-10-25","current":-0.111702,"twenty":-0.743234,"median":-0.515682,"eighty":-0.066488,"marketCap":15308680},{"date":"2024-10-31","current":-0.109715,"twenty":-0.741526,"median":-0.508851,"eighty":-0.066652,"marketCap":15036392},{"date":"2024-11-08","current":-0.111592,"twenty":-0.739321,"median":-0.498158,"eighty":-0.06682,"marketCap":15293553},{"date":"2024-11-15","current":-0.123204,"twenty":-0.736132,"median":-0.492107,"eighty":-0.067201,"marketCap":16884930},{"date":"2024-11-22","current":-0.096923,"twenty":-0.734509,"median":-0.489621,"eighty":-0.06743,"marketCap":13645248},{"date":"2024-11-29","current":-0.098427,"twenty":-0.734469,"median":-0.48099,"eighty":-0.067496,"marketCap":13857037},{"date":"2024-12-06","current":-0.108407,"twenty":-0.733312,"median":-0.130241,"eighty":-0.067596,"marketCap":15262104},{"date":"2024-12-13","current":-0.104014,"twenty":-0.729414,"median":-0.121316,"eighty":-0.067685,"marketCap":14643681},{"date":"2024-12-20","current":-0.114642,"twenty":-0.725217,"median":-0.114642,"eighty":-0.068025,"marketCap":16139817},{"date":"2024-12-27","current":-0.244993,"twenty":-0.723719,"median":-0.117501,"eighty":-0.068353,"marketCap":34491315},{"date":"2025-01-03","current":-0.186323,"twenty":-0.723452,"median":-0.123204,"eighty":-0.068427,"marketCap":26231553},{"date":"2025-01-10","current":-0.173429,"twenty":-0.722482,"median":-0.130241,"eighty":-0.069344,"marketCap":24416220},{"date":"2025-01-17","current":-0.146996,"twenty":-0.721141,"median":-0.147157,"eighty":-0.069786,"marketCap":20694789},{"date":"2025-01-24","current":-0.13797,"twenty":-0.719413,"median":-0.140763,"eighty":-0.070056,"marketCap":19424056},{"date":"2025-01-31","current":-0.156666,"twenty":-0.718444,"median":-0.146996,"eighty":-0.070643,"marketCap":22056288},{"date":"2025-02-07","current":-0.178157,"twenty":-0.715773,"median":-0.153981,"eighty":-0.07105,"marketCap":25081842},{"date":"2025-02-14","current":-0.173739,"twenty":-0.713859,"median":-0.157526,"eighty":-0.072709,"marketCap":24459897},{"date":"2025-02-21","current":-0.121618,"twenty":-0.713592,"median":-0.156666,"eighty":-0.073848,"marketCap":17121928},{"date":"2025-02-28","current":-0.087129,"twenty":-0.71288,"median":-0.149414,"eighty":-0.074131,"marketCap":12266456},{"date":"2025-03-07","current":-0.070533,"twenty":-0.710432,"median":-0.144632,"eighty":-0.071013,"marketCap":9929988},{"date":"2025-03-14","current":-0.07157,"twenty":-0.706225,"median":-0.135069,"eighty":-0.071013,"marketCap":10076017},{"date":"2025-03-21","current":-0.074682,"twenty":-0.703145,"median":-0.130241,"eighty":-0.070984,"marketCap":10514105},{"date":"2025-03-28","current":-0.066643,"twenty":-0.70173,"median":-0.123448,"eighty":-0.070533,"marketCap":9382378},{"date":"2025-04-04","current":-0.066422,"twenty":-0.698614,"median":-0.121618,"eighty":-0.069679,"marketCap":11060862},{"date":"2025-04-11","current":-0.053321,"twenty":-0.692996,"median":-0.117957,"eighty":-0.068372,"marketCap":8879132},{"date":"2025-04-17","current":-0.060633,"twenty":-0.690629,"median":-0.115407,"eighty":-0.067596,"marketCap":10096842},{"date":"2025-04-25","current":-0.046618,"twenty":-0.687348,"median":-0.111751,"eighty":-0.066971,"marketCap":7762898},{"date":"2025-05-02","current":-0.042961,"twenty":-0.674063,"median":-0.111618,"eighty":-0.066488,"marketCap":7154043},{"date":"2025-05-06","current":-0.045704,"twenty":-0.670346,"median":-0.111536,"eighty":-0.066096,"marketCap":7610685}],"updateTime":1746680115455}}}